← Eichor
Study identifier: NCT03836950 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

rTMS to Improve Cognition in Parkinson's

Condition: Parkinson's Disease · Mild Cognitive Impairment  ·  Sponsor: VA Office of Research and Development

PhasePhase 1/Phase 2
Planned participants56
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to examine safety, feasibility, and the behavioral and brain effects of a non-invasive treatment, repetitive transcranial magnetic stimulation (rTMS), for Veterans with Parkinson's disease or atypical parkinsonism and mild impairments in their thinking. The hypothesis is that rTMS can improve thinking for people with Parkinson's disease or atypical parkinsonism who are experiencing mild problems with their thinking ability.

This description comes directly from the study's public registry record.

Talk to the study team

Sandra L Kletzel, PhD BA  ·  (708) 202-5735  ·  Sandra.Kletzel@va.gov

Alexandria N Umbarger, BS  ·  (708) 998-8213  ·  alexandria.umbarger@va.gov

Always discuss trial participation with your own doctor first.

Locations (2)

Jesse Brown VA Medical Center, Chicago, ILChicago, Illinois, United StatesNot Yet Recruiting
Edward Hines Jr. VA Hospital, Hines, ILHines, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03836950